Japan, Feb. 18 -- INTELLIA THERAPEUTICS INC,REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR TRANSGENE EXPRESSION FROM ALBUMIN LOCUS.' Other related details are as follows:

Application Number: JP,2024-063210

Category (FI): A61K35/76,A61K47/44,A61K48/00,A61K9/14,A61P1/16,A61P43/00,105,C12N15/09,100,C12N15/09,110,C12N15/113@Z,C12N15/12,C12N15/55,C12N15/861@Z,C12N15/864,100@Z,C12N15/867@Z,C12N15/86@Z,C12N15/88@Z,C12N15/90@Z,C12N5/10,C12N9/22,C12P21/02@C

Stage: Grant (IP right granted following substantive examination.)

Filing Date: April 10, 2024

Publication Date: July 25, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syn...